Ramakrishnan Sivasubramanian, Faisal Nabeel Valappil, Kadiyani Lamk, Gupta Saurabh Kumar, Sivaprakasam Muthukumaran Chinnasamy
Department of Cardiology, All India Institute of Medical Sciences, New Delhi, India.
Department of Pediatric Cardiology, Apollo Hospitals, Chennai, Tamil Nadu, India.
Ann Pediatr Cardiol. 2024 Jul-Aug;17(4):281-284. doi: 10.4103/apc.apc_166_24. Epub 2024 Nov 15.
Transcatheter pulmonary valve implantation (TPVI) is the standard of care in patients with repaired tetralogy of Fallot (rTOF) presenting with right ventricular outflow tract (RVOT) dysfunction. However, the feasibility of TPVI is limited by the high cost and nonavailability of larger-sized valves for dilated native RVOT of rTOF patients. We report the first successful TPVI with a custom-made 35 mm balloon-expandable valve (Myval™) in a 30-year-old rTOF patient with severe pulmonary regurgitation and RV dysfunction.
经导管肺动脉瓣植入术(TPVI)是患有法洛四联症修复术后(rTOF)且出现右心室流出道(RVOT)功能障碍患者的标准治疗方法。然而,TPVI的可行性受到高成本以及rTOF患者扩张的原生RVOT较大尺寸瓣膜无法获得的限制。我们报告了首例在一名30岁患有严重肺动脉反流和RV功能障碍的rTOF患者中成功使用定制的35毫米球囊扩张瓣膜(Myval™)进行TPVI的病例。